Investigation into the potential of iontophoresis facilitated delivery of ketorolac

International Journal of Pharmaceutics

Volumn 260, Issue 1, 2003, Pages 93-103

  Tiwari, Sandip B ^a,b   Udupa, N ^a  

^a MANIPAL COLLEGE OF PHARMACEUTICAL SCIENCES   (India)

^b ZYDUS RESEARCH CENTRE   (India)

Author keywords

Ethanol; Iontophoresis; Ketorolac; Limonene; Penetration enhancer; Transdermal drug delivery; Ultrasound

Indexed keywords

ALCOHOL; KETOROLAC; LIMONENE; PLATINUM; SILVER; SILVER CHLORIDE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DIFFUSION; DRUG PENETRATION; DRUG TRANSPORT; ELECTRODE; IONIC STRENGTH; IONTOPHORESIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN PERMEABILITY; ULTRASOUND;

EID: 0038006697     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(03)00249-7     Document Type: Article

References (34)

1. Banga A.K., Chien Y.W. Iontophoretic delivery of drugs: fundamental development and biomedical application. J. Cont. Rel. 7:1988;1-24.
2. Bhatia K.S., Singh J. Effect of linoleic acid/ethanol or limonene/ethanol and iontophoresis on the in vitro percutaneous absorption of LHRH and ultrastructure of human epidermis. Int. J. Pharm. 180:1999;235-250.
3. Bhatia K.S., Gao S., Freeman T.P., Singh J. Effect of penetration enhancers and iontophoresis on the ultrastructure and cholecystokinin-8 permeability through porcine skin. J. Pharm. Sci. 86:1997;1011-1015.
4. Brand R.M., Duensing G., Hamel F.G. Iontophoretic delivery of an insulin-mimetic peroxovanadium compound. Int. J. Pharm. 146:1997;115-122.
5. Buckley M.M.-T., Brogden R.N. Ketorolac: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs. 39:1990;86-109.
6. + permeability of excised nude mouse skin. J. Pharm. Sci. 77:1988;492-497.
7. Clemessy M., Couarraze G., Bevan B., Puisieux F. Mechanisms involved in iontophoretic transport of angiotensin. Pharm. Res. 12:1995;998-1002.
8. Durrheim H., Flynn G.L., Higuchi W.I., Bhel C.R. Permeation of hairless mouse skin. I. Experimental methods and comparison with human epidermal permeation by alkanols. J. Pharm. Sci. 69:1980;781-786.
9. Elving P.J., Markowitz J.M., Rosenthal I. Preparation of buffer systems for constant ionic strength. Anal. Chem. 28:1956;1179-1180.
10. Green P.G. Iontophoretic delivery of peptide drugs. J. Cont. Rel. 41:1996;33-48.
11. Green P.G., Hinz R.S., Cullander C., Yamane G., Guy R.H. Iontophoreitc delivery of amino acids and amino acid derivatives across the skin in vitro. Pharm. Res. 8:1991a;1113-1120.
12. Green P.G., Hinz R.S., Kim A., Frnacis C., Guy R.H. Jr. Iontophoretic delivery of a series of tripeptides across the skin in vitro. Pharm. Res. 8:1991b;1121-1127.
13. Lelawongs P., Liu J.-C., Siddiqui O., Chien Y.W. Transdermal iontophoretic delivery of arginine-vasopressin (I): physicochemical considerations. Int. J. Pharm. 56:1989;13-22.
14. Li S.K., Ghanem A.-H., Peck K.D., Higuchi W.I. Iontophoretic transport across a synthetic membrane and human epidermal membrane: a study of the effects of permanent charge. J. Pharm. Sci. 86:1997;680-689.
15. Litvak K.M., McEvoy G.K. Ketorolac, an injectable non-narcotic analgesic. Clin. Pharm. 9:1990;921-935.
16. Martin, A., Bustamante, P., Chun, A.H.C., 1994. Physical Pharmacy: Physical Chemical Principles in the Pharmaceutical Sciences. B.I. Waverly, New Delhi, p. 135.
17. Phipps, J.B., Scott, E.R., Gyory, J.R., Padmanabhan, R.V., 2002. Iontophoresis. In: Swarbrick, J., Boylan, J.C. (Eds.), Encyclopedia of Pharmaceutical Technology, 2nd ed. Marcel Dekker, New York, pp. 1573-1587.
18. Pikal M.J., Shah S. Study of the mechanism of flux enhancement through hairless mouse skin by pulsed dc iontophoresis. Pharm. Res. 8:1991;365-369.
19. Preat V., Thysman S. Transdermal iontophoretic delivery of sufentanil. Int. J. Pharm. 96:1993;189-196.
20. Riviere J.E., Heit M.C. Electrically-assisted transdermal drug delivery. Pharm. Res. 14:1997;687-697.
21. Roy S.D., Manoukian E. Transdermal delivery of ketorolac tromethamine: permeation enhancement, device design, and pharmacokinetics in healthy humans. J. Pharm. Sci. 84:1995;1190-1196.
22. Roy S.D., Manoukian E., Combs D. Absorption of transdermal delivered ketorolac acid in humans. J. Pharm. Sci. 84:1995;49-52.
23. Sage, B.H., 1995. Iontophoresis. In: Smith, E.W., Maibach, H.I. (Eds.), Percutaneous Penetration Enhancers. CRC Press, Boca Raton, FL, pp. 351-368.
24. Sanderson J.E., Riel S.D., Dixon R. Iontophoretic delivery of non-peptide drugs: formulation optimization for maximum skin permeability. J. Pharm. Sci. 78:1989;361-364.
25. Siddiqui O., Roberts M.S., Polack A.E. The effect of iontophoresis and vehicle pH on the in vitro permeation of lignocaine through human stratum corneum. J. Pharm. Pharmacol. 37:1985;732-735.
26. Simonin J.-P. On the mechanism of in vitro and in vivo phonophoresis. J. Cont. Rel. 33:1995;125-141.
27. Singh P., Roberts M.S. Iontophoretic transdermal delivery of salicylic acid and lidocaine to local subcutaneous structures. J. Pharm. Sci. 82:1993;127-131.
28. Srinivasan V., Higuchi W.I. A model for iontophoresis incorporating the effect of convective solvent flow. Int. J. Pharm. 60:1990;133-138.
29. Srinivasan V., Higuchi W.I., Sims S.M., Ghanem A.H., Behl C.R. Transdermal iontophoretic drug delivery: mechanistic analysis and application to polypeptide delivery. J. Pharm. Sci. 78:1989;370-375.
30. Thysman S., Preat V., Roland M. Factors affecting iontophoretic mobility of metoprolol. J. Pharm. Sci. 81:1992;670-675.
31. Thysman S., Tasset C., Preat V. Transdermal iontophoresis of fentanyl: delivery and mechanistic analysis. Int. J. Pharm. 101:1994;105-113.
32. Tiwari S.B., Udupa N. Low cost mini magnetic stirrers for application in pharmacy. Ind. J. Pharm. Educ. 33:1999;223-224.
33. Varghese E., Khar R.K. Enhanced skin permeation of diclofenac by iontophoresis: in vitro and in vivo studies. J. Cont. Rel. 38:1996;21-27.
34. Yamamoto T., Yamamoto Y. Electrical properties of the epidermal stratum corneum. Med. Biol. Eng. 14:1976;151-156.